All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

@primenutrition.pe's MK-677 growth hormone claims checked

Prime Nutrition

TikTok creator

75.8K viewsWatch on TikTok→

Quick answer

MK-677 (ibutamoren) is an orally active ghrelin receptor agonist that stimulates pituitary GH release and raises IGF-1 levels. It has been studied in clinical trials for growth hormone deficiency and muscle wasting but has never received FDA approval for any indication, making its sale for human use legally and medically unsanctioned. Documented adverse effects in trials include increased fasting glucose, insulin resistance, water retention, and appetite stimulation, which are clinically relevant risks being omitted in this promotional content.

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team· This is not a transcript. It is our independent review of the video above.

What did @primenutrition.pe actually say?

Honestly, the transcript here is largely unintelligible. The auto-generated captions appear to be a corrupted or mistranslated rendering of what was likely a Spanish-language video about MK-677 and growth hormone. The caption itself, though, is clear enough: the creator is promoting MK-677 as worth using for growth hormone elevation, offering a "protocol PDF" via DM, and linking to a product for sale. The closing phrase "Soreto's Cresimiento, ita la pazo" is a garbled transliteration of something like "sobre el crecimiento" (about growth). So while we cannot quote the spoken content directly, the commercial intent and the central claim are explicit in the post itself.

The framing is a classic TikTok soft-sell: ask a question ("Is MK-677 worth it?"), tease a guide, and drop a purchase link. That structure shapes what claims are likely being made, even if the transcript can't confirm them word for word.

Does the science back the core premise?

MK-677, also known as ibutamoren, does reliably increase growth hormone (GH) and IGF-1. That part is real. The question is whether the effect is beneficial, safe, or appropriate outside of clinical settings. The honest answer is: it depends heavily on context, and the risks are routinely underplayed by influencers.

MK-677 is a ghrelin receptor agonist, not a peptide in the strict sense, that stimulates the pituitary to release GH. Studies do confirm this mechanism. Nass et al. (2008, Annals of Internal Medicine) found that MK-677 increased GH and IGF-1 in older adults over two years, but also found a significant increase in fasting glucose and insulin resistance. Svensson et al. (1998, Journal of Clinical Endocrinology and Metabolism) confirmed the GH-stimulating effect in healthy adults. So the "raises growth hormone" claim? Accurate. But the side effect profile is real and not trivial. Water retention, increased appetite (it mimics ghrelin, the hunger hormone), elevated blood sugar, and potential worsening of insulin sensitivity are documented. For someone with pre-diabetes or metabolic syndrome, this compound could cause measurable harm.

What did they get wrong, or right?

Credit where it is due: MK-677 does raise GH and IGF-1, and that is not snake oil. The underlying mechanism is reasonably well-studied for a compound that has never received FDA approval for any indication. It reached Phase II trials for growth hormone deficiency and muscle wasting before development was discontinued.

What the creator appears to get wrong, based on the promotional framing, is the risk-benefit calculation. Selling a "protocol PDF" implies this is something you can self-administer with the right instructions. It is not. MK-677 has no approved human dose. It has no approved human indication. The FDA has not cleared it for any use. Selling it for human consumption is legally ambiguous at best. More practically, influencers promoting GH secretagogues to general audiences are not screening for the populations most likely to be harmed: people with insulin resistance, active cancers (GH and IGF-1 are mitogenic), sleep apnea, or pituitary disorders. Posting a purchase link alongside a protocol guide, with no medical history intake, is not responsible health content regardless of how well the compound works in a controlled trial.

What should you actually know?

If you are interested in growth hormone support, the evidence base for lifestyle interventions is actually solid and carries none of the legal or metabolic risk. Ho et al. (1988, Journal of Clinical Investigation) established that even a single bout of high-intensity exercise acutely spikes GH. Slow-wave sleep is the largest driver of endogenous GH release, and sleep deprivation measurably blunts it. Intermittent fasting has also shown GH-elevating effects in multiple studies, including Hartman et al. (1992, Journal of Clinical Endocrinology and Metabolism).

If you are working with a licensed clinician who has evaluated your labs and health history, peptide or secretagogue therapy may be a legitimate conversation to have. But "comment 'Crecimiento' and I'll send you a PDF" is not a medical evaluation. It is a lead generation funnel. The compound being promoted may do something real. The context in which it is being promoted is not appropriate for self-directed use. Those are two different things, and conflating them is how people get hurt.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

Peptide social video fact-checksMedical claim reviewProvider discussion

Evidence signal

Source-backed review

Regulatory reality

Access rules depend on the compound and patient situation

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 10 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For @primenutrition.pe's MK-677 growth hormone claims checked, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Provider decision path

Use local research to choose a safer review path

Direct answer

@primenutrition.pe's MK-677 growth hormone claims checked is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.

Evidence check

Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.

Safety check

Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.

Next step

Compare providers, services and access requirements in the directory before contacting a suitable care team.

Claim verdict

The useful answer behind this video

Claim being checked

MK-677 (ibutamoren) is an orally active ghrelin receptor agonist that stimulates pituitary GH release and raises IGF-1 levels.

FormBlends verdict

MK-677 (ibutamoren) is an orally active ghrelin receptor agonist that stimulates pituitary GH release and raises IGF-1 levels. It has been studied in clinical trials for growth hormone deficiency and muscle wasting but has never received FDA approval for any indication, making its sale for human use legally and medically unsanctioned. Documented adverse effects in trials include increased fasting glucose, insulin resistance, water retention, and appetite stimulation, which are clinically relevant risks being omitted in this promotional content.

Patient-safe next step

Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • MK-677 (ibutamoren) is an orally active ghrelin receptor agonist that stimulates pituitary GH release and raises IGF-1 levels. It has been studied in clinical trials for growth hormone deficiency and muscle wasting but has never received FDA approval for any indication, making its sale for human use legally and medically unsanctioned. Documented adverse effects in trials include increased fasting glucose, insulin resistance, water retention, and appetite stimulation, which are clinically relevant risks being omitted in this promotional content.
  • MK-677 raises GH and IGF-1 in human trials, but it has no FDA-approved indication and was discontinued before receiving one.
  • Nass et al. (2008, Annals of Internal Medicine) found MK-677 increased fasting glucose and worsened insulin sensitivity over a 2-year trial, a risk omitted in most influencer content.

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • Compound access, legal status, and product quality still need a separate safety check.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.

Start provider review

What You'll Learn

  • MK-677 raises GH and IGF-1 in human trials, but it has no FDA-approved indication and was discontinued before receiving one.
  • Nass et al. (2008, Annals of Internal Medicine) found MK-677 increased fasting glucose and worsened insulin sensitivity over a 2-year trial, a risk omitted in most influencer content.
  • MK-677 mimics ghrelin, meaning appetite stimulation and water retention are expected pharmacological effects, not rare side effects.
  • People with insulin resistance, pre-diabetes, active or prior cancer, or pituitary disorders face elevated risk from GH secretagogues and should not self-administer based on social media content.
  • High-intensity exercise reliably spikes GH acutely (Ho et al., 1988, Journal of Clinical Investigation) with no metabolic downside, making it a first-line option before any compound is considered.
  • Selling MK-677 for human consumption via a social media link is legally ambiguous in most jurisdictions because it is not an approved drug or supplement.
  • Any legitimate use of GH secretagogues requires baseline labs including fasting glucose, HbA1c, and IGF-1, none of which a PDF protocol can assess or monitor.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

Prime Nutrition · TikTok creator

75.8K views on this video

😱Vale la pena usar MK677? 👉Comenta "Crecimiento" para enviarte una guía PDF con el protocolo de uso adecuado y otras estrategias para aumentar tu hormona de crecimiento de forma natural. 👉Consígue

Sources & references

Citations extracted from our medical team's review. Click any citation to search PubMed.

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Read More on This Topic

Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.

Not medical advice. This video was made by Prime Nutrition, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.